Navigation Links
Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
Date:11/4/2008

LAKE FOREST, Ill., Nov. 4 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that Christopher B. Begley, chairman and chief executive officer, and Thomas E. Werner, senior vice president, Finance, and chief financial officer, will make a formal presentation at the 2008 Annual Credit Suisse Health Care Conference on Wednesday, Nov. 12, 2008, in Phoenix.

The presentation is scheduled to begin at noon Mountain time on Wednesday, Nov. 12, 2008. It will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's Web site at http://www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the audiocast. The slides accompanying the presentation will be available on the Hospira Web site. A replay of the webcast will be available on the Hospira Web site approximately 24 hours after the live presentation.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection
2. Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
3. Hospira Reports Second-Quarter 2008 Results
4. Hospira Hosts Conference Call for Second-Quarter 2008 Earnings
5. Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders
6. Hospira to Present at the Bank of America 2008 Health Care Conference on May 14
7. Hospira Acquires Sculptor
8. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
9. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
10. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
11. Hospira Launches Generic Irinotecan Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Stevens Hospital Expand, Improve Quality of Care and ... The Board of Commissioners for Public ... non-binding terms for Swedish to lease and assume ... summer, pending regulatory approvals and final agreements. The ... to learn more about the affiliation. A final ...
(Date:12/17/2009)... most effective when it comes from physician, study finds ... advice has the most influence in convincing parents to ... in order to prevent sudden infant death syndrome, or ... launched the "Back to Sleep" campaign in 1994, the ... time has increased from 25 percent to 70 percent, ...
(Date:12/17/2009)... clothing stores, gas stations -- and adding to obesity epidemic, ... you,re hungry while shopping for a new sofa, don,t despair: ... salty snacks, a new report finds. , In fact, the ... stores to hit most segments of the retail market, say ... the American Journal of Public Health . The ...
(Date:12/17/2009)... the cast takes the stage at the Fisher Theatre on Dec. ... cancer patients and cancer survivors will be the real stars of ... ... -- When the cast takes the stage at the Fisher Theatre ... “Jersey Boys,” Beaumont cancer patients and cancer survivors will ...
(Date:12/17/2009)... might be more likely to try alcohol, illegal drugs ... believe that smoking cigarettes is riskier than using illicit ... , That perception may increase the likelihood that they,ll ... said. , "We are on the right track with ... teens about the dangers of other substances," Pamela S. ...
Breaking Medicine News(10 mins):Health News:Stevens Hospital to Affiliate with Swedish 2Health News:Stevens Hospital to Affiliate with Swedish 3Health News:Stevens Hospital to Affiliate with Swedish 4Health News:Doctor's Orders Influence Baby's Sleep Position 2Health News:Wide Array of Stores Now Sell High-Calorie Snacks 2Health News:Jersey Boys' Premiere Benefits Cancer Patients While Launching Beaumont Hospitals Fundraising Campaign 2Health News:Jersey Boys' Premiere Benefits Cancer Patients While Launching Beaumont Hospitals Fundraising Campaign 3Health News:Teens Think Smoking More Dangerous Than Drinking, Drugs 2
... DTC Perspectives Inc., the leading DTC training, publishing and ... and DTC Perspectives Magazine , announced today the ... will serve the unmet needs of OTC Marketers, and ... to focus on the myriad of emerging issues OTC ...
... the largest rollouts of Digital Dictation technology within the NHS produces ... ... 7, 2009 -- BigHand has today announced that Sheffield Teaching Hospitals ... incorporating over 1000 users spanning 5 hospitals on 2 campuses in ...
... a.m. Eastern Standard Time Duplin County , ... , Locations of Initial Recruitment WASHINGTON, Jan. 7 ... A media telephone briefing and webcast to announce the beginning ... health study in the United States, the National Children,s study will ...
... FARMINGDALE, N.Y., Jan. 6 Dieters craving a ... pounds can now find a refreshing option at ... Integrated Beverage Group, Ltd. (IBG). The company, a ... announced major new relationships with leading distributors, retailers ...
... GPRO ) announced today that the Company will present ... January 14, 2009 at 3 p.m. Pacific time (6 p.m. ... and may be accessed through a link on the investors ... will be available for 30 days following the event. About ...
... Jan. 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... license rights to SB1518, an orally available, potent, and selective ... JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore. ... rights to exclusively develop and commercialize SB1518 (designated by Onyx ...
Other Medicine News:Health News:Crucial OTC Marketing Issues to be Addressed by New OTC Perspectives Division of DTC Perspectives, Inc. 2Health News:Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation 2Health News:Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation 3Health News:Telebriefing: National Children's Study Recruitment Begins 2Health News:Skinny Dippers(TM), First Zero-Calorie Frozen Dessert, Earns Widespread Retail, Online Distribution 2Health News:Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference 2Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 2Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 3Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 4
(Date:12/17/2009)... N.J., Dec. 17 CANTEL MEDICAL CORP. ... its Board of Directors intends to pay, for the ... outstanding share, or $0.10 per share annually, on the ... dividend of $0.05 per share of outstanding common stock, ... of record at the close of business on January ...
(Date:12/17/2009)... 17 Decision Resources, one of the ... and healthcare issues, finds that the cost of ... and side-effect profile, are cited most frequently by ... of Avastin for non-small-cell lung cancer treatment in ... ,, The new Special European Physician & Payer ...
(Date:12/17/2009)... 17 MedX Limited, the manufacturer and ... equipment and a subsidiary of WellTek Incorporated (OTC ... 227 MedX exercise and ... including Australia, Germany, India, Scotland, South Korea, Spain ... equipment will be used in various medical ...
Breaking Medicine Technology:Cantel Medical Authorizes Semiannual Dividend 2Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer 2Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer 3WellTek Subsidiary MedX Limited Increases Presence in Global Market 2WellTek Subsidiary MedX Limited Increases Presence in Global Market 3WellTek Subsidiary MedX Limited Increases Presence in Global Market 4Fastrack Automates Workflow For Homecare Providers 52355 1Fastrack Automates Workflow For Homecare Providers 52355 2Fastrack Automates Workflow For Homecare Providers 52355 3CAeHC Demonstrates NHIN enabled Gateways Among Five California Health Information Exchanges 52353 1CAeHC Demonstrates NHIN enabled Gateways Among Five California Health Information Exchanges 52353 2CAeHC Demonstrates NHIN enabled Gateways Among Five California Health Information Exchanges 52353 3CAeHC Demonstrates NHIN enabled Gateways Among Five California Health Information Exchanges 52353 4CAeHC Demonstrates NHIN enabled Gateways Among Five California Health Information Exchanges 52353 5CAeHC Demonstrates NHIN enabled Gateways Among Five California Health Information Exchanges 52353 6The MedZilla Report 3A June 2009 Employment Outlook for Biotech Pharma Health 13134 1The MedZilla Report 3A June 2009 Employment Outlook for Biotech Pharma Health 13134 2The MedZilla Report 3A June 2009 Employment Outlook for Biotech Pharma Health 13134 3
For the quantitative determination of iron, total iron-binding capacity in human serum....
HDL Cholesterol, liquid....
Cholesterol/HDL with 200 tests....
For the quantitative determination of High Density Lipoprotein in serum. Available in liquid type. Polyethylene glycol (6000) precipitating reagent. Linearity: 200 mg/dl....
Medicine Products: